Female guinea pigs which had been infected genitafly with the agent of guinea pig inclusion conjunctivitis were chaflenged at various times after infection with fresh inocula to determine the duration of immunity resulting from the primary infection. 
and genital secretions (IgA, IgG) was observed after 30 days. A decrease in antibodies to the major outer membrane protein and an 84K component was noted in serum. In genital secretions, IgA antibodies to all major chlamydial components declined markedly after 30 days. Cell-mediated immunity as measured by proliferation of peripheral blood lymphocytes to guinea pig inclusion conjunctivitis antigen also was at a peak response 30 days after infection and decreased thereafter. Thus, loss of complete immunity could not be associated with a particular immune parameter. When genital secretions were examined 14 days after the challenge infection, IgA antibody levels to the lipopolysaccharide and 61K protein components had increased in intensity, whereas other antibodies were relatively low. In addition, complete immunity to a third infection was not increased in duration when animals had recovered from two previous genital infections.
An interesting and significant aspect of chlamydial genital infections is that individuals who have acquired and resolved an infection, usually by antibiotic therapy, remain susceptible to reinfection. Indeed, multiple episodes of chlamydial infection are not uncommon (9, 16) . Although most repeat infections are probably caused by reexposure to an infected individual, some may be the result of a recrudescence of organisms which have survived inadequate antimicrobial therapy. Others may be caused by the reactivation of a latent form of chlamydiae. Regardless of the mechanisms by which a "new" infection occurs, it is important to recognize that long-lasting immunity does not occur as a result of the previous exposure to the organism despite the development of antibody in both serum and genital secretions (8) and of cell-mediated immunity (CMI) as indicated by lymphocyte stimulation assays (5, 6) .
Some evidence indicates that immunity may be produced by a chlamydial genital infection (2, 15) , although the duration of that immunity may be relatively short. For example, when patients at risk for infection had cultures for chlamydiae, those who had had a positive culture less than 6 months before were significantly less likely to be isolation positive than those who were isolation positive more than 6 months before. The immune mechanisms involved and the reasons for the short duration of protection have not been defined.
We have previously observed that female guinea pigs infected in the genital tract with the agent of guinea pig inclusion conjunctivitis (GPIC) are resistant to reinfection shortly after resolution of the infection (11) but can be reinfected at much later times (3) . However, even at this point, a measurable degree of protection is evident in that the challenge infection is of shorter duration and intensity. We know from earlier work that both humoral immunity (14) and CMI (12) Assessment of infection. The course of the infection was assessed by the collection of both vaginal smears for determination of inclusion scores and cervical swabs for isolation of chlamydiae. Vaginal smears were obtained by inserting a stainless steel dental plastic instrument about 1.5 cm into the vaginal vault and gently scraping the wall. A smear was made and stained with Giemsa; the inclusion score, defined as the percentage of inclusion-bearing cells, was determined. After collecting material for the smear, a wire dacron swab (Dacroswab, type 1; Spectrum Diagnostics, Houston, Tex.) was inserted to the cervix, where it was rotated while applying slight pressure. The swab was immediately placed into 1 ml of transport medium (sucrose-potassium buffer supplemented with 3% fetal calf serum, 50 ,ug of gentamicin per ml, 100 ,ug of vancomycin per ml, and 2.5 ,ug of amphotericin B per ml) (17) . All specimens were frozen at -70°C until cultured.
For isolation of chlamydiae in culture, 1.3 ml of Eagle minimum essential medium containing 10% fetal calf serum, 3 mg of glucose per ml, 0.5 ,ug of cycloheximide per ml, 50 ,ug of gentamicin per ml, 100 ,ug of vancomycin per ml, and 2.5 ,ug of amphotericin B per ml was added to each specimen tube. The tube was vigorously agitated, and 1 ml was added to a shell vial containing a cover slip with a McCoy cell monolayer. The specimen was centrifuged for 1 h at 1,900 x g at 37°C, followed by incubation for 2 h at 37°C. The medium was changed, and the cultures were incubated for 24 h. Cover slips were fixed with methanol, incubated with guinea pig anti-GPIC agent serum followed by fluoresceinlabeled rabbit anti-guinea pig immunoglobulin G (IgG; ICN ImmunoBiologicals, Lisle, Ill.) and examined by fluorescent microscopy to visualize inclusions. Specimens were only assessed as positive or negative; quantitative cultures were not attempted.
Because of the greater sensitivity of chlamydial culture of cervical swabs, it was quite common that vaginal smears would be negative for inclusions while cervical swabs were isolation positive for the GPIC agent. Cultures were always strongly positive whenever inclusions could be detected on smears, even when the inclusion score was <1%. However, use of inclusion scores gave a quantitative aspect to the determination of the infection course.
Measurement of serum and secretion antibody to the GPIC agent. Serum and genital secretions were obtained as described previously (13, 14) . Genital secretions were not collected on the same day that vaginal smears or cervical swabs were taken. Antibody specific for the GPIC agent was determined by an enzyme-linked immunosorbent assay (13) . IgG was measured in both serum and secretions by using peroxidase-labeled rabbit anti-guinea pig IgG (H and L chain specific) (ICN); IgA was measured in secretions by using rabbit anti-guinea pig IgA (alpha chain specific) (ICN) followed by peroxidase-labeled goat anti-rabbit IgG (ICN).
Assessment of antigen-specific antibody response by inmunoblotting. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis, electrophoretic transfer of chlamydial proteins to nitrocellulose membranes, and subsequent immunoblotting assays were performed as previously described (3) . In all cases, blocking of nitrocellulose membranes was accomplished by using a solution containing 150 mM NaCl-10 mM Tris-0.5% (wt/vol) nonfat Carnation dry milk (pH 7.4).
Guinea pig serum specimens were diluted 1:1,000. Vaginal secretions specimens were diluted 1:40 for assays for IgA and 1:200 for assays for IgG. A sufficient volume of secretion was not always available to prepare a 1:40 dilution. In such cases, the entire specimen was used for the IgA assay (maximum dilution, 1:80), and the secretion assay for IgG was omitted. Localization of antibody binding was accomplished by using rabbit anti-guinea pig IgG (heavy and light chain specific) or IgA (alpha-chain specific) (Miles Laboratories, Inc., Naperville, Ill.) followed by radioiodinated goat anti-rabbit IgG (Cooper Biomedical, Inc., West Chester, Pa.). Although the immunoblotting procedure is not inherently quantitative, attempts were made to include specimens to be compared on nitrocellulose strips from the same antigen preparation and to have all run at the same time with the same reagents. Thus, a crude quantitation could be made by comparing relative staining intensity of the bands.
Antigen-specific blastogenesis. Guinea pigs were anesthetized with methoxyflurane and bled by cardiac puncture, and the blood was mixed with sodium citrate. The blood samples, usually 3 to 4 ml per guinea pig, were individually diluted with 3 volumes of phosphate-buffered saline (pH 7.2) and centrifuged at 400 x g for 40 min over Ficoll-Isopaque (1.077 g/ml; Sigma Chemical Co., St. Louis, Mo.). The interface cells were collected, washed twice, and placed into microculture at 2 x 105 cells per well in RPMI 1640 containing 10% fetal calf serum, 50 nM 2-mercaptoethanol, and added glutamine and antibiotics. UV-inactivated GPIC agent elementary bodies were added to triplicate wells at 16 pug of protein per ml. Cultures were labeled with 1 ,uCi of [3H]thymidine per ml over the final 24 h of a 5-day incubation at 37°C in 5% CO2. Cultures were filtered on a multipleautomated cell harvester (Bellco Glass, Inc., Vineland, N.J.) and counted in a liquid scintillation counter (Packard). Results are reported as the means ± standard errors of the results from five replicate animals.
Experimental design. In the first experiment, groups of five guinea pigs each were infected intravaginally with the GPIC agent, and each group was then challenged with a new inoculum at either 30, 77, 155, or 294 days after initiation of the primary infection (Table 1) . Previously uninfected animals (three animals each) were challenged concomitantly with the first three groups to confirm infectivity of the inoculum. These animals also served as age-matched controls with which the course of the challenge infections could be compared. Before the challenge infection, serum, secretions, and peripheral blood lymphocytes were collected to assess the humoral and cell-mediated immune responses to the GPIC agent at that particular point after the primary infection. To determine whether multiple infections enhance immunity, the first three groups were challenged a second time at various times after the first challenge. The experiment was repeated as indicated in Table 1 .
RESULTS
Course of challenge infection at various times after primary infection. When guinea pigs were inoculated 30 days after a primary genital tract infection with the GPIC agent, organisms could be isolated from only two animals for 3 to 6 days, whereas naive animals infected concurrently developed a normal infection (Table 2) . In contrast, all guinea pigs challenged at 77, 155, and 294 days after infection became reinfected. For the day 77 and 155 challenges, the second infection lasted 3 to 9 days, whereas the infections in the day 294 group ranged from 9 to 18 days. In the latter group, specimens were not collected after day 18, so that the actual duration of infection could not be determined for four of five animals. The infections in the animals challenged on day 30 were significantly shorter than those of the other groups when compared by a Tukey multiple-comparison procedure (P < 0.05). Furthermore, the course of the challenge infections in each of the day 30, 77, and 155 challenge groups was significantly different from that of the control group with a primary infection when compared by a Kruskal-Wallis nonparametric one-way analysis of variance (P < 0.001). This test could not be applied to compare the day 294 group with the control group, but the infection in the day 294 group was significantly lower in intensity when inclusion scores were compared with the control group by a two-way analysis of variance with repeated measures on one variable (P < 0.001).
When this experiment was repeated (experiment 2), similar responses were obtained (data not shown). Only one to five animals challenged on day 30 became reinfected, whereas all animals challenged at the latter times became reinfected. However, reinfections in each group were still shorter in length and markedly lower in intensity as judged by inclusion score than a primary infection. Generally, the infection could only be detected by isolation of organisms from cervical swabs. Since the titer of the challenge inoculum on day 30 in experiment 1 was lower than that on the following days, a higher inoculum was used in experiment 2 on day 30 (1.2 x 107 organisms). Similar results were obtained, indicating that the dose was not the crucial factor in the first experiment at day 30. These data indicate that complete immunity to reinfection, as measured by the inability to detect chlamydiae by isolation at any time after challenge, is relatively short in duration. Nevertheless, animals do retain partial immunity for a long time.
Antibody response at time of challenge infection. The loss of complete immunity shortly after resolution of infection would indicate that a decrease in an essential immune function occurs at that time. Therefore, we examined several parameters of humoral immunity and CMI in experiment 1 to determine whether the loss of any of these could be associated with the loss of complete immunity. When antibody levels in serum and genital secretions were measured, the highest amounts of both serum and secretion IgG and secretion IgA were found before challenge on day 28 (Fig. 1) . By day 75, serum IgG, secretion IgG, and secretion IgA levels had decreased significantly (P < 0.001, P < 0.05, and P < 0.025, respectively; one-tailed t test). Titers remained at about the same level at days 150 and 292. Increases in serum and secretion antibody titers were routinely seen by 7 to 14 days after challenge, indicating that an anamnestic response had occurred (data not shown).
The antigen-specific antibody responses were also assessed to determine whether susceptibility to reinfection could be associated with the loss of antibodies to a specific chlamydial component. Figure 2 shows the serum IgG responses for each group of animals immediately before the challenge inoculation. Antibodies to two antigens, the 61K The IgG response in genital secretions before challenge infection was also determined in animals who had a sufficient volume of secretions remaining after the IgA assay (Fig. 4) . The 61K and LPS responses were long-lived and consistent. The 84K responses became less frequent with increasing time elapsing from the primary infection. The antibody response to MOMP was quite variable from animal to animal. The intensities of the reactions in individual animals generally correlated with their serum reactions, suggesting that the IgG in secretions was derived from serum.
The anamnestic response of IgA antibodies in vaginal secretions was assessed in each of the four groups at 7 and 14 days after the challenge infection. Only the day 14 samples are shown in Fig. 5 , but day 7 responses were basically the same. Strong responses to the 61K protein and LPS developed in all four groups, whereas the responses to the other components, including MOMP, were weak and variable. The reactions to 61K and LPS were much more intense at days 7 and 14 than those before challenge, particularly when the samples from animals before and after challenge at days 77 and 155 were compared.
Cell-mediated immune response at time of challenge infection. The lymphocyte stimulation response to GPIC antigen was measured on peripheral blood lymphocytes before challenge to determine whether a decrease in T cell reactivity might be associated with the susceptibility to reinfection (Fig. 6) . Maximum stimulation occurred at day 28, but the responses were lower when animals were tested at 77 and 155 days after infection. A parallel group of five guinea pigs was monitored at various times after primary intravaginal infection to determine the kinetics of the CMI response when repeated measures were made on individual animals (Fig. 6) . The lymphocyte proliferation also peaked about day 25 and then diminished gradually thereafter. There was wide variation among individual animals with regard to the degree of stimulation, but each animal remained consistent in the relative intensity of its response. The pattern of the response for each animal is reflected by the mean values shown in Fig.  6 . When antigen-specific stimulation was tested 7 to 14 days after challenge infection, variable reactions were recorded, ranging from a decrease in stimulation to a slight increase (data not shown).
Effect of multiple infections on immunity. To determine whether two infections would elicit longer-lasting immunity, animals were given a third infection at various times after the second. Animals became susceptible to reinfection if an interval of at least 77 days was between two infections (Fig.  7) . It did not matter whether the animal had two previous infections or only one, i.e., two infections did not enhance the degree of immunity to a third infection. Complete immunity was routinely present only at 30 days after the previous infection. In experiment 1, three animals at 108 days and one animal at 155 days after the secondary challenge demonstrated solid immunity. These data were prob- 1 (0, 0) and 2 (A, A) . Each figure represents a single animal. Closed symbols indicate that the animal became reinfected as assessed by isolation of chlamydiae from genital swabs. Open figures indicate that no organisms were isolated and that these animals had complete immunity. Infection doses are given in Table 1. ably the result of the lower dose used in the tertiary challenge, indicating that the degree of immunity is to some extent dose dependent. When the experiment was repeated (experiment 2) with higher inocula, complete immunity to reinfection was only seen at 30 days.
When the animals did become infected as a result of the tertiary challenge, the infection course was similar to those of the secondary infections (Table 2) . Partial immunity was evident, as indicated by markedly reduced inclusion scores and by reduced duration of shedding (6 to 9 days).
DISCUSSION
Epidemiological studies in humans suggest that immunity to chlamydial genital infections may indeed develop but may be short lived (9) . In this study, we have observed that female guinea pigs infected genitally with the GPIC agent develop complete immunity to reinfection but that this immunity is also short lasting. Whereas animals are virtually refractory to challenge infection within 12 days after resolution of a primary infection, they become susceptible to reinfection by as early as 50 days after resolution. Thus, the data in the guinea pig model support the observations in humans. Even though guinea pigs can be reinfected, they possess a marked immunity as reflected by a decreased intensity of infection and an abbreviated infection course. However, as the interval between the primary and challenge infections becomes longer, the course of the infection becomes longer and inclusion scores increase, indicating a gradual waning of the protective response. Similar observations have been made with regard to GPIC ocular infections (1, 10) . Johnson et al. (7) have also reported that female marmosets infected in the genital tract with Chlamydia trachomatis (types D/E and H) became reinfected upon challenge. In some cases there was evidence for partial immunity, which seemed to be related to the time between infections. Whether partial immunity develops in humans is presently unknown.
We have also examined several immune parameters in an attempt to identify those components which may be associated with protective immunity. Previously, we reported that an intact humoral immune response is required for resistance to a challenge infection (11) . Animals were noted. The antibody response in serum and genital secretions was highest when tested at the 30-day time point and then decreased thereafter. Similarly, the antigen-specific blastogenic response was also at its peak about the time that complete immunity was seen but decreased as time progressed. Thus, a decline in either or both of these responses could be related to the loss of solid immunity.
Since it was possible that an antibody response to a critical protective antigen may have been lost or diminished in comparison to other less critical antibodies, we evaluated the antigen-specific antibody response to chlamydial antigens by immunoblot analysis. Serum antibody before the day 30 challenge showed that antibodies to the major membrane components (MOMP, 61K, 84K, LPS) were present but that the antibodies to MOMP and 84K had markedly diminished in staining intensity by the time of the day 77, 155, and 294 challenges. The antibodies bound to 61K and LPS remained at comparatively high levels throughout. A similar pattern was noted in secretions when IgA responses were measured; i.e., antibody to MOMP disappeared first, whereas only weak levels of anti-61K and anti-LPS could be measured after 30 days. However, in the secretions, IgA antibodies to all components, as assessed by immunoblotting, decreased dramatically in staining intensity. These data supported our previous observations on the kinetics of the antigen-specific antibody response (3). It is difficult to conclude that the loss of antibodies to MOMP is responsible for the loss of solid immunity, since it is just as likely that the overall decrease in IgA titers to several antigens was a key factor. It is interesting to note that Brunham et al. (4) observed that the number of inclusion-forming units per milliliter in positive cultures of cervices of women was inversely correlated with the presence of specific IgA in genital secretions.
Although we did not study the anamnestic response in detail, some interesting observations can be made. In general, antibody levels in serum and secretions began to increase by about 7 to 14 days after challenge. Of significance was the finding that the first antibodies to reappear or increase were those which were directed against the 61K and LPS components. The appearance of these antibodies corresponded with the resolution of the challenge infection. Antibodies to MOMP did not appear as quickly or as consistently. These data suggest that the 61K or LPS moiety or both may bear epitopes responsible for protective immunity. If this is the case, the possibility exists that the protective epitope(s) is genus specific.
An important point in this study is that despite a diminution of immunity, a marked degree of immunity did persist for a long period of time as reflected by the decreased intensity and shortened duration of the challenge infections. Obviously, critical immune functions are operative during this time. As we have seen, both IgA and IgG antibodies can be detected in secretions for long periods of time, albeit at gradually decreasing levels. They may be sufficient to retard the chlamydial infection until an anamnestic response develops. In this light, it is noteworthy that high levels of antibodies to 61K and LPS persist considerably longer in secretions and serum than the antibodies to MOMP. These data by no means rule out an important contribution of antibodies to MOMP or, for that matter, the CMI response in the maintenance of this long-term immunity.
Several hypotheses have been forwarded to explain the observations that individuals may become reinfected with chlamydiae. The most likely explanation would be that immunity does develop but wanes very quickly as a result of factors described above. It is also possible that antibiotic therapy which interrupts the infection course may prevent adequate antigen exposure to elicit a protective immune response. At least in the guinea pig, this would not appear to be the case, since the infection course is allowed to run its full length and animals still become susceptible to reinfection. Furthermore, we have noted that although antibiotic intervention of GPIC genital infection delays the development of immunity, it does develop to the same degree as that in untreated animals (R. G. Rank and N. K. Schmucker, unpublished data).
We have also demonstrated in this study that guinea pigs infected twice are as susceptible to reinfection as animals infected only once. The critical factor is the length of the interval between exposures, regardless of the number of times the animals are infected. Thus, the protective effect of the anamnestic response does not last any longer than the protection resulting from the primary infection, and one could presume that the same immune functions that decline after a primary infection do so in the same amount of time after a secondary infection. Certainly, in humans, individuals have been reported to have multiple infections, so that each episode has no apparent long-lasting immune benefits. It is possible that each infection may result in short-term immunity as indicated in the study of Katz et al. (9) and the guinea pig model; but as soon as the immunity subsides, the individuals can again be infected.
